| Literature DB >> 27838450 |
Guili Liu1, Huihui Ji1, Jing Liu1, Chunshuang Xu1, Lan Chang1, Wei Cui1, Cong Ye1, Haochang Hu1, Yingmin Chen1, Xiaohui Zhou2, Shiwei Duan3, Qinwen Wang4.
Abstract
As the pre-dementia phase of Alzheimer disease, mild cognitive impairment (MCI) involves the onset and development of cognitive impairments. Opioid receptors play pivotal roles in the regulation of learning and cognition. Our study focused on the association of OPRK1 and OPRM1 methylation with MCI in Xinjiang Uygur and Han populations. DNA methylation was measured using bisulphite pyrosequencing method. Our results indicated OPRK1 was significantly hypermethylated in Xinjiang Han MCI females. Meanwhile, OPRM1 CpG1 hypermethylation and CpG2-4 hypomethylation were associated with MCI risk in Xinjiang Uygur and Han, respectively. Our study showed that OPRK1 and OPRM1 were significantly hypermethylated in Xinjiang (Northwest China) than Zhejiang (Southeast China) Han Chinese healthy controls. Our results showed that OPRK1 promoter methylation was related to gender, ethnicity, aging, and environmental changes, while OPRM1 promoter methylation was related to blood lipids and living regions. Dual-luciferase reporter gene assays revealed that promoter fragments of OPRK1 and OPRM1 were able to upregulate gene expression. In summary, our findings provided novel aspects of OPRK1 and OPRM1 methylation in Xinjiang Uygur and Han populations. Copyright ÂEntities:
Keywords: DNA methylation; Mild cognitive impairment; OPRK1; OPRM1; Opioid receptor; Peripheral blood
Mesh:
Substances:
Year: 2016 PMID: 27838450 DOI: 10.1016/j.neulet.2016.11.018
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046